| Literature DB >> 33507376 |
Max J Kääb1, Georges Kohut2, Ulrich Irlenbusch3, Thierry Joudet4, Falk Reuther5.
Abstract
INTRODUCTION: Reverse total shoulder arthroplasty (RTSA) is a widely recognized treatment to reduce pain and improve shoulder function for patients in various disease stages of cuff tear arthropathy (CTA). However, it remains unclear whether outcomes after RTSA depend on the preoperative stage of CTA. Therefore, this study evaluated whether the Hamada classification influences midterm clinical outcomes after RTSA.Entities:
Keywords: Cuff tear arthropathy; Hamada classification; Massive rotator cuff tears; Midterm clinical outcome; Predictors; Reverse total shoulder arthroplasty
Mesh:
Year: 2021 PMID: 33507376 PMCID: PMC9217847 DOI: 10.1007/s00402-021-03755-w
Source DB: PubMed Journal: Arch Orthop Trauma Surg ISSN: 0936-8051 Impact factor: 2.928
Fig. 1Radiographic images of Hamada classification grades
Baseline characteristics according to Hamada group
| Characteristic | Group 1 ( | Group 2 ( | |
|---|---|---|---|
| Age at surgery mean ± SD (range) years | 74.3 ± 6.9 (41.9–91.6) | 75.7 ± 6.2 (55.3–87.3) | 0.089 |
| Gender, | |||
| Male | 40 (37) | 29 (28) | 0.17 |
| Female | 68 (63) | 74 (72) | |
| Hamada classification, | |||
| Grade 1 | 13 | – | |
| Grade 2 | 52 | – | |
| Grade 3 | 43 | – | |
| Grade 4a | – | 44 | |
| Grade 4b | – | 50 | |
| Grade 5 | – | 9 | |
| Rheumatoid arthritis, | |||
| Yes | 2 (2) | 4 (4) | 0.37 |
| No | 106 (98) | 99 (96) | |
| ASA classification, | |||
| ASA I | 12 (11) | 6 (6) | |
| ASA II | 35 (32) | 29 (28) | |
| ASA III + | 46 (43) | 64 (62) | |
| Unknown | 15 (14) | 4 (4) | |
| Surgical approach, | |||
| Deltopectoral | 70 (65) | 56 (54) | 0.12 |
| Deltoid split | 38 (35) | 47 (46) | |
| Follow-up, | |||
| 24 months | 53 (49) | 44 (43) | 0.96 |
| > 30 months | 83 (77) | 68 (66) | 0.30 |
n refers to the number of shoulders
ASA American Society of Anesthesiologists, SD standard deviation
*Statistically significant
Bold value are statistically significant
Clinical outcomes according to Hamada group
| Outcome | Follow-up | ||
|---|---|---|---|
| Preoperative | 24 months | > 30 months | |
| Constant score (points) | |||
| Group 1 | 26.2 (14.4) | 66.8 (15.7) | 63.4 (17.4) |
| Group 2 | 23.8 (13.2) | 68.0 (14.0) | 62.6 (15.6) |
| | 0.25 | 0.82 | 0.33 |
| ASES score (points) | |||
| Group 1 | 20.2 | 76.4 (17.1) | 79.7 (18.1) |
| Group 2 | 20.0 | 79.2 (16.4) | 75.3 (22.0) |
| | 0.82 | 0.41 | 0.17 |
| ROM for abduction (°) | |||
| Group 1 | 71.3 (38.4) | 128.7 (40.3) | 132.5 (36.4) |
| Group 2 | 62.9 (36.2) | 133.6 (34.0) | 124.6 (36.0) |
| | 0.12 | 0.73 | 0.14 |
| VAS for pain | |||
| Group 1 | 7.9 (1.7) | 1.2 (1.5) | 0.9 (1.6) |
| Group 2 | 7.7 (1.8) | 0.8 (1.4) | 1.4 (2.4) |
| | 0.63 | 0.18 | 0.26 |
| VAS for satisfaction | |||
| Group 1 | 1.9 (1.6) | 8.9 (1.3) | 9.0 (1.6) |
| Group 2 | 2.1 (1.9) | 9.2 (1.1) | 8.5 (2.5) |
| | 0.48 | 0.14 | 0.55 |
Values given as means (standard deviations)
ASES American Shoulder and Elbow Surgeons, VAS visual analog scale, ROM range of motion
Fig. 2Kaplan–Meier survivorship analysis for survival free from any implant component revision according to Hamada group